I would agree with your comment but NP was very ca

I would agree with your comment but NP was very careful to not discuss the "fee" they would be getting from the PO, and he went out of his way to say they will not share the cost to the PI. I assume they don't want to get locked into the discounted price for future opportunities. I don't see any way for them to release a PR about the PO without giving the total revenue and number of treatments (i.e vials). If so, anyone can do the math to determine the discounted price.

I hope I'm wrong, and I guess we'll know by the end of the week.

Quote:

---

He wont sit on it. No way.

---

My comments are just my opinions and should NOT be taken as investment advice.